Monocyte recruitment and foam cell formation in atherosclerosis.

Atherosclerosis is a chronic immune-inflammatory disease in which the interactions of monocytes with activated endothelium are crucial events leading to atherosclerotic alteration of the arterial intima. In early atherosclerosis, monocytes migrate into the subendothelial layer of the intima where they differentiate into macrophages or dendritic cells. In the subendothelial space enriched with atherogenic lipoproteins, most macrophages transform into foam cells. Foam cells aggregate to form the atheromatous core and as this process progresses, the atheromatous centres of plaques become necrotic, consisting of lipids, cholesterol crystals and cell debris. This review highlights some aspects of monocyte recruitment and foam cell formation in atherosclerosis.

[1]  J. Neefjes,et al.  E-selectin and intercellular adhesion molecule-1 are released by activated human endothelial cells in vitro. , 1992, Immunology.

[2]  M. Takeichi,et al.  The cadherins: cell-cell adhesion molecules controlling animal morphogenesis. , 1988, Development.

[3]  Gerrity Rg The role of the monocyte in atherogenesis: I. Transition of blood-borne monocytes into foam cells in fatty lesions. , 1981 .

[4]  U. Steinbrecher,et al.  Oxidized low density lipoprotein is resistant to cathepsins and accumulates within macrophages. , 1991, The Journal of biological chemistry.

[5]  K. Matsumoto,et al.  CD36, a novel receptor for oxidized low-density lipoproteins, is highly expressed on lipid-laden macrophages in human atherosclerotic aorta. , 1999, Arteriosclerosis, thrombosis, and vascular biology.

[6]  A. Zernecke,et al.  Involvement of JAM-A in Mononuclear Cell Recruitment on Inflamed or Atherosclerotic Endothelium: Inhibition by Soluble JAM-A , 2005, Arteriosclerosis, thrombosis, and vascular biology.

[7]  E. Fisher,et al.  Emigration of monocyte-derived cells from atherosclerotic lesions characterizes regressive, but not progressive, plaques. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[8]  J. Borén,et al.  Subendothelial retention of atherogenic lipoproteins in early atherosclerosis , 2002, Nature.

[9]  O. Quehenberger,et al.  Thematic Review Series: the Immune System and Atherogenesis Molecular Mechanisms Regulating Monocyte Recruitment in Atherosclerosis Thematic Review , 2005 .

[10]  A. C. Nicholson,et al.  CD36, oxidized LDL and PPARγ: pathological interactions in macrophages and atherosclerosis , 2004 .

[11]  M. Takeichi,et al.  Cadherin cell adhesion receptors as a morphogenetic regulator. , 1991, Science.

[12]  A. Zernecke,et al.  Inflammatory mediators in atherosclerotic vascular disease , 2005, Basic Research in Cardiology.

[13]  Qingbo Xu,et al.  Atherosclerosis, autoimmunity, and vascular‐associated lymphoid tissue , 1997, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[14]  Timothy A. Springer,et al.  Adhesion receptors of the immune system , 1990, Nature.

[15]  K. Moore,et al.  Loss of receptor-mediated lipid uptake via scavenger receptor A or CD36 pathways does not ameliorate atherosclerosis in hyperlipidemic mice. , 2005, The Journal of clinical investigation.

[16]  Y. Bobryshev,et al.  Formation of Birbeck granule-like structures in vascular dendritic cells in human atherosclerotic aorta. Lag-antibody to epidermal Langerhans cells recognizes cells in the aortic wall. , 1997, Atherosclerosis.

[17]  A. Zernecke,et al.  JAM-1 is a ligand of the β2 integrin LFA-1 involved in transendothelial migration of leukocytes , 2002, Nature Immunology.

[18]  M. Davies,et al.  The expression of the adhesion molecules ICAM‐1, VCAM‐1, PECAM, and E‐selectin in human atherosclerosis , 1993, The Journal of pathology.

[19]  R. Stocker,et al.  Lipid oxidation in atherogenesis: an overview. , 2004, Biochemical Society transactions.

[20]  L. Stanton,et al.  CD36 is a receptor for oxidized low density lipoprotein. , 1993, The Journal of biological chemistry.

[21]  Y. Bobryshev,et al.  Phenotype determination of anti-GM3 positive cells in atherosclerotic lesions of the human aorta. Hypothetical role of ganglioside GM3 in foam cell formation. , 2001, Biochimica et biophysica acta.

[22]  Y. Bobryshev,et al.  The cell adhesion molecule E-cadherin is widely expressed in human atherosclerotic lesions. , 1998, Cardiovascular research.

[23]  Andrew C. Li,et al.  The macrophage foam cell as a target for therapeutic intervention , 2002, Nature Medicine.

[24]  D. Greaves,et al.  Atherosclerosis: role of chemokines and macrophages , 2001, Expert Reviews in Molecular Medicine.

[25]  J. Skepper,et al.  Macrophage death and the role of apoptosis in human atherosclerosis. , 2001, Journal of hematotherapy & stem cell research.

[26]  N. Maeda,et al.  Absence of CC chemokine receptor-2 reduces atherosclerosis in apolipoprotein E-deficient mice. , 1999, Atherosclerosis.

[27]  M. Ala-Korpela,et al.  Aggregation, fusion, and vesicle formation of modified low density lipoprotein particles: molecular mechanisms and effects on matrix interactions. , 2000, Journal of lipid research.

[28]  M. Parkes,et al.  Ulcerative colitis and Crohn's disease: molecular genetics and clinical implications , 2001, Expert Reviews in Molecular Medicine.

[29]  Y. Bobryshev,et al.  Neovascular expression of VE-cadherin in human atherosclerotic arteries and its relation to intimal inflammation. , 1999, Cardiovascular research.

[30]  K. Pettigrew,et al.  Increased endothelial expression of intercellular adhesion molecule-1 in symptomatic versus asymptomatic human carotid atherosclerotic plaque. , 1998, Stroke.

[31]  V. Mehra,et al.  Cytokines and cardiovascular disease , 2005, Journal of leukocyte biology.

[32]  W D Wagner,et al.  A definition of advanced types of atherosclerotic lesions and a histological classification of atherosclerosis. A report from the Committee on Vascular Lesions of the Council on Arteriosclerosis, American Heart Association. , 1995, Arteriosclerosis, thrombosis, and vascular biology.

[33]  Richard G. W. Anderson,et al.  Reversible accumulation of cholesteryl esters in macrophages incubated with acetylated lipoproteins , 1979, The Journal of cell biology.

[34]  M. Cybulsky,et al.  Leukocyte recruitment to atherosclerotic lesions. , 2004, The Canadian journal of cardiology.

[35]  M. Linton,et al.  Conditional Knockout of Macrophage PPARγ Increases Atherosclerosis in C57BL/6 and Low-Density Lipoprotein Receptor–Deficient Mice , 2005, Arteriosclerosis, thrombosis, and vascular biology.

[36]  J. Boyle,et al.  Macrophage activation in atherosclerosis: pathogenesis and pharmacology of plaque rupture. , 2005, Current vascular pharmacology.

[37]  K. Williams,et al.  Lipoprotein retention--and clues for atheroma regression. , 2005, Arteriosclerosis, thrombosis, and vascular biology.

[38]  M. Ilyas,et al.  THE INTERACTIONS OF APC, E‐CADHERIN AND β‐CATENIN IN TUMOUR DEVELOPMENT AND PROGRESSION , 1997, The Journal of pathology.

[39]  I. Charo,et al.  Chemokines in the pathogenesis of vascular disease. , 2004, Circulation research.

[40]  Qingbo Xu,et al.  Autoimmune and inflammatory mechanisms in atherosclerosis. , 2004, Annual review of immunology.

[41]  François Mach,et al.  Inflammation and Atherosclerosis , 2004, Herz.

[42]  V. Babaev,et al.  Monocyte/macrophage accumulation and smooth muscle cell phenotypes in early atherosclerotic lesions of human aorta. , 1993, Atherosclerosis.

[43]  J. Loscalzo,et al.  Cellular adhesion molecules and atherogenesis. , 1999, The American journal of medicine.

[44]  M. Linton,et al.  ACAT inhibition: bad for macrophages, good for smooth muscle cells? , 2005, Arteriosclerosis, thrombosis, and vascular biology.

[45]  P. Libby,et al.  Macrophage colony-stimulating factor gene expression in vascular cells and in experimental and human atherosclerosis. , 1992, The American journal of pathology.

[46]  J. Plutzky,et al.  Atherosclerotic plaque rupture: emerging insights and opportunities. , 1999, The American journal of cardiology.

[47]  S. Blankenberg,et al.  Adhesion molecules and atherosclerosis. , 2003, Atherosclerosis.

[48]  M. Ala-Korpela,et al.  Structure of low density lipoprotein (LDL) particles: basis for understanding molecular changes in modified LDL. , 2000, Biochimica et biophysica acta.

[49]  R. Steinman,et al.  Dendritic cells and the control of immunity , 1998, Nature.

[50]  D. Steinberg,et al.  A macrophage receptor that recognizes oxidized low density lipoprotein but not acetylated low density lipoprotein. , 1989, The Journal of biological chemistry.

[51]  D. Altshuler,et al.  The role of PPAR-γ in macrophage differentiation and cholesterol uptake , 2001, Nature Medicine.

[52]  P. Libby Inflammation in atherosclerosis , 2002, Nature.

[53]  E. Smart,et al.  Macrophage scavenger receptors and foam cell formation , 1999, Journal of leukocyte biology.

[54]  Roger A. Davis,et al.  Differential inhibition of macrophage foam-cell formation and atherosclerosis in mice by PPARα, β/δ, and γ , 2004 .

[55]  W D Wagner,et al.  A definition of initial, fatty streak, and intermediate lesions of atherosclerosis. A report from the Committee on Vascular Lesions of the Council on Arteriosclerosis, American Heart Association. , 1994, Arteriosclerosis and thrombosis : a journal of vascular biology.

[56]  R. Steinman,et al.  Differentiation of monocytes into dendritic cells in a model of transendothelial trafficking. , 1998, Science.

[57]  P. Libby,et al.  Distinct patterns of expression of fibroblast growth factors and their receptors in human atheroma and nonatherosclerotic arteries. Association of acidic FGF with plaque microvessels and macrophages. , 1993, The Journal of clinical investigation.

[58]  G. Byrne,et al.  A Chlamydia pneumoniae Component That Induces Macrophage Foam Cell Formation Is Chlamydial Lipopolysaccharide , 1998, Infection and Immunity.

[59]  S. Wesselborg,et al.  Role of peroxisome proliferator-activated receptor gamma and its ligands in the control of immune responses. , 2003, Critical reviews in immunology.

[60]  C. Alpers,et al.  Neovascular expression of E-selectin, intercellular adhesion molecule-1, and vascular cell adhesion molecule-1 in human atherosclerosis and their relation to intimal leukocyte content. , 1996, Circulation.

[61]  K. Matsumoto,et al.  Expression of human scavenger receptor class B type I in cultured human monocyte-derived macrophages and atherosclerotic lesions. , 1999, Circulation research.

[62]  M. Takeya,et al.  Multifunctional roles of macrophages in the development and progression of atherosclerosis in humans and experimental animals , 2002, Medical Electron Microscopy.

[63]  G. Hansson Immune mechanisms in atherosclerosis. , 1989, Arteriosclerosis, thrombosis, and vascular biology.

[64]  S. Hazen,et al.  Targeted disruption of the class B scavenger receptor CD36 protects against atherosclerotic lesion development in mice. , 2000, The Journal of clinical investigation.

[65]  T. Kodama,et al.  Scavenger receptor deficiency leads to more complex atherosclerotic lesions in APOE3Leiden transgenic mice. , 1999, Atherosclerosis.

[66]  B. Staels,et al.  The role of PPARs in atherosclerosis. , 2002, Trends in molecular medicine.

[67]  S. Gordon,et al.  Recent progress in defining the role of scavenger receptors in lipid transport, atherosclerosis and host defence. , 1998, Current opinion in lipidology.

[68]  Y. Bobryshev,et al.  Ultrastructural recognition of cells with dendritic cell morphology in human aortic intima. Contacting interactions of Vascular Dendritic Cells in athero-resistant and athero-prone areas of the normal aorta. , 1995, Archives of histology and cytology.

[69]  T. Kodama,et al.  Role of macrophage scavenger receptors in diet-induced atherosclerosis in mice. , 1998, Laboratory investigation; a journal of technical methods and pathology.

[70]  G. Byrne,et al.  Induction of macrophage foam cell formation by Chlamydia pneumoniae. , 1998, The Journal of infectious diseases.

[71]  Z. Lijun,et al.  Role of macrophage and smooth muscle cell apoptosis in association with oxidized low-density lipoprotein in the atherosclerotic development , 2005, Modern Pathology.

[72]  V. Fuster,et al.  Macrophage Infiltration in Acute Coronary Syndromes: Implications for Plaque Rupture , 1994, Circulation.

[73]  T. Carew,et al.  Initiation of atherosclerotic lesions in cholesterol-fed rabbits. I. Focal increases in arterial LDL concentration precede development of fatty streak lesions. , 1989, Arteriosclerosis.

[74]  J. Ge,et al.  Ciglitazone Inhibits Oxidized-Low Density Lipoprotein Induced Immune Maturation of Dendritic Cells , 2004, Journal of cardiovascular pharmacology.

[75]  P. Yancey,et al.  Crystallization of free cholesterol in model macrophage foam cells. , 1999, Arteriosclerosis, thrombosis, and vascular biology.

[76]  P. Yancey,et al.  The Role of Microscopy in Understanding Atherosclerotic Lysosomal Lipid Metabolism , 2003, Microscopy and Microanalysis.

[77]  J L Witztum,et al.  Lipoproteins and atherogenesis. Current concepts. , 1990, JAMA.

[78]  Robert V Farese,et al.  Impaired monocyte migration and reduced type 1 (Th1) cytokine responses in C-C chemokine receptor 2 knockout mice. , 1997, The Journal of clinical investigation.

[79]  E. Chavakis,et al.  The role of junctional adhesion molecule‐C (JAM‐C) in oxidized LDL‐mediated leukocyte recruitment , 2005, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[80]  H. Kruth Sequestration of aggregated low-density lipoproteins by macrophages , 2002, Current opinion in lipidology.

[81]  A. Daugherty,et al.  Thematic review series: The Immune System and Atherogenesis. Cytokine regulation of macrophage functions in atherogenesis Published, JLR Papers in Press, July 1, 2005. DOI 10.1194/jlr.R500009-JLR200 , 2005, Journal of Lipid Research.

[82]  R. Gerrity,et al.  The role of the monocyte in atherogenesis: II. Migration of foam cells from atherosclerotic lesions. , 1981, The American journal of pathology.

[83]  Jody C. Ullery,et al.  Aggregated LDL and lipid dispersions induce lysosomal cholesteryl ester accumulation in macrophage foam cells Published, JLR Papers in Press, July 16, 2005. DOI 10.1194/jlr.M500059-JLR200 , 2005, Journal of Lipid Research.

[84]  A. Varki,et al.  Selectin ligands. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[85]  E. Ikonen,et al.  Macrophage cholesterol transport: a critical player in foam cell formation , 2003, Annals of medicine.

[86]  Yukiko Kurihara,et al.  A role for macrophage scavenger receptors in atherosclerosis and susceptibility to infection , 1997, Nature.

[87]  B. Ludewig,et al.  The in and out of monocytes in atherosclerotic plaques: Balancing inflammation through migration. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[88]  A. G. Vinogradov,et al.  Lipoprotein-antibody immune complexes. Their catabolism and role in foam cell formation. , 1985, Atherosclerosis.

[89]  M. Brown,et al.  The scavenger cell pathway for lipoprotein degradation: specificity of the binding site that mediates the uptake of negatively-charged LDL by macrophages. , 1980, Journal of supramolecular structure.

[90]  C. Funk,et al.  The 5-lipoxygenase pathway in arterial wall biology and atherosclerosis. , 2005, Biochimica et biophysica acta.

[91]  H. Kruth,et al.  Macrophage Foam Cell Formation with Native Low Density Lipoprotein* , 2002, The Journal of Biological Chemistry.

[92]  I. Tabas,et al.  Cholesterol and phospholipid metabolism in macrophages. , 2000, Biochimica et biophysica acta.

[93]  K. Moore,et al.  Scavenger Receptors Class A-I/II and CD36 Are the Principal Receptors Responsible for the Uptake of Modified Low Density Lipoprotein Leading to Lipid Loading in Macrophages* , 2002, The Journal of Biological Chemistry.

[94]  Y. Bobryshev Dendritic cells in atherosclerosis: current status of the problem and clinical relevance. , 2005, European heart journal.

[95]  G. Hansson Inflammation, atherosclerosis, and coronary artery disease. , 2005, The New England journal of medicine.

[96]  W. Rabl,et al.  A Previously Unrecognized Site of Local Accumulation of Mononuclear Cells , 1998, The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society.

[97]  R. Poston,et al.  Increase in the adhesion molecule P-selectin in endothelium overlying atherosclerotic plaques. Coexpression with intercellular adhesion molecule-1. , 1994, The American journal of pathology.

[98]  V. Ord,et al.  Macrophage colony-stimulating factor mRNA and protein in atherosclerotic lesions of rabbits and humans. , 1992, The American journal of pathology.

[99]  H. Itabe Oxidized low-density lipoproteins: what is understood and what remains to be clarified. , 2003, Biological & pharmaceutical bulletin.

[100]  Peter Libby,et al.  Innate and Adaptive Immunity in the Pathogenesis of Atherosclerosis , 2002, Circulation research.

[101]  R. Ross The pathogenesis of atherosclerosis: a perspective for the 1990s , 1993, Nature.

[102]  D. Malide,et al.  Macropinocytosis Is the Endocytic Pathway That Mediates Macrophage Foam Cell Formation with Native Low Density Lipoprotein* , 2005, Journal of Biological Chemistry.

[103]  G. Hansson,et al.  Chemokines and atherosclerosis , 2004, Annals of medicine.

[104]  M. Linton,et al.  Macrophages, inflammation, and atherosclerosis , 2003, International Journal of Obesity.

[105]  A. C. Nicholson Expression of CD36 in macrophages and atherosclerosis: the role of lipid regulation of PPARgamma signaling. , 2004, Trends in cardiovascular medicine.

[106]  Siamon Gordon,et al.  Thematic review series: The Immune System and Atherogenesis. Recent insights into the biology of macrophage scavenger receptors Published, JLR Papers in Press, November 16, 2004. DOI 10.1194/jlr.R400011-JLR200 , 2005, Journal of Lipid Research.

[107]  S. Yamashita,et al.  Localization of CD36 and scavenger receptor class A in human coronary arteries--a possible difference in the contribution of both receptors to plaque formation. , 2001, Atherosclerosis.

[108]  S. Hirohashi,et al.  Cadherin cell-adhesion molecules in human epithelial tissues and carcinomas. , 1989, Cancer research.

[109]  K. Ley,et al.  Macrophage differentiation to foam cells. , 2005, Current pharmaceutical design.

[110]  T. Carew,et al.  Initiation of atherosclerotic lesions in cholesterol-fed rabbits. II. Selective retention of LDL vs. selective increases in LDL permeability in susceptible sites of arteries. , 1989, Arteriosclerosis.

[111]  M. Freeman Scavenger receptors in atherosclerosis , 1997, Current opinion in hematology.

[112]  P. Kovanen,et al.  Proteolysis of the Pericellular Matrix: A Novel Element Determining Cell Survival and Death in the Pathogenesis of Plaque Erosion and Rupture , 2004, Arteriosclerosis, thrombosis, and vascular biology.

[113]  Y. Bobryshev,et al.  Subset of vascular dendritic cells transforming into foam cells in human atherosclerotic lesions. , 1997, Cardiovascular pathology : the official journal of the Society for Cardiovascular Pathology.

[114]  T. Cohnert,et al.  Expanding expression of the 5-lipoxygenase pathway within the arterial wall during human atherogenesis , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[115]  T. Kodama,et al.  Reduced Atherosclerotic Lesions in Mice Deficient for Total or Macrophage-Specific Expression of Scavenger Receptor-A , 2000, Arteriosclerosis, thrombosis, and vascular biology.

[116]  M. Linton,et al.  Class A scavenger receptors, macrophages, and atherosclerosis , 2001, Current opinion in lipidology.

[117]  M. Linton,et al.  ACAT1 Deficiency Disrupts Cholesterol Efflux and Alters Cellular Morphology in Macrophages , 2004, Arteriosclerosis, thrombosis, and vascular biology.

[118]  B. Chain,et al.  Effects of oxidised low density lipoprotein on dendritic cells: a possible immunoregulatory component of the atherogenic micro-environment? , 2002, Cardiovascular research.

[119]  Klaus Ley,et al.  L-Selectin Shedding Regulates Leukocyte Recruitment , 2001, The Journal of experimental medicine.

[120]  V. Fuster,et al.  Evolving Concepts in the Triad of Atherosclerosis, Inflammation and Thrombosis , 2004, Journal of Thrombosis and Thrombolysis.

[121]  Y. Bobryshev Intracellular Localization of Oxidized Low-density Lipoproteins in Atherosclerotic Plaque Cells Revealed by Electron Microscopy Combined with Laser Capture Microdissection , 2005, The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society.

[122]  R. Natarajan,et al.  Monocyte retention in the pathology of atherosclerosis. , 2005, Future cardiology.

[123]  S. Heidenreich Monocyte CD14: a multifunctional receptor engaged in apoptosis from both sides , 1999, Journal of leukocyte biology.

[124]  H. Hammad,et al.  Peroxisome Proliferator-Activated Receptor γ Inhibits the Migration of Dendritic Cells: Consequences for the Immune Response1 , 2003, The Journal of Immunology.

[125]  W. Brugger,et al.  Dendritic Cell Immunogenicity Is Regulated by Peroxisome Proliferator-Activated Receptor γ1 , 2002, The Journal of Immunology.

[126]  K. Gaus,et al.  Oxidized lipoproteins and macrophages. , 2002, Vascular pharmacology.

[127]  Y. Bobryshev,et al.  Dendritic cells and their involvement in atherosclerosis , 2000, Current opinion in lipidology.

[128]  M. Ferguson,et al.  Vascular cell adhesion molecule-1 is expressed in human coronary atherosclerotic plaques. Implications for the mode of progression of advanced coronary atherosclerosis. , 1993, The Journal of clinical investigation.

[129]  G. Byrne,et al.  Chlamydia pneumoniae and atherosclerosis: links to the disease process. , 1999, American heart journal.

[130]  Y. Bobryshev,et al.  Mapping of vascular dendritic cells in atherosclerotic arteries suggests their involvement in local immune-inflammatory reactions. , 1998, Cardiovascular research.

[131]  H. Niederegger,et al.  Network of Vascular-Associated Dendritic Cells in Intima of Healthy Young Individuals , 2001, Arteriosclerosis, thrombosis, and vascular biology.

[132]  H. Aburatani,et al.  Human macrophage scavenger receptors: primary structure, expression, and localization in atherosclerotic lesions. , 1990, Proceedings of the National Academy of Sciences of the United States of America.

[133]  I. Tabas Consequences and Therapeutic Implications of Macrophage Apoptosis in Atherosclerosis: The Importance of Lesion Stage and Phagocytic Efficiency , 2005, Arteriosclerosis, thrombosis, and vascular biology.

[134]  D. Rader,et al.  Lipoproteins, macrophage function, and atherosclerosis: beyond the foam cell? , 2005, Cell metabolism.

[135]  N. E. Rossett,et al.  Peptic ulcer: medical cure by efficient gastric acid neutralization. , 1952, Annals of internal medicine.